Skip to content
Disclosery

Eagle Health Investments LP

Follow

13F filer, CIK 1842545, Greenwich, CT

Eagle Health Investments LP reported $571,789,551 across 28 holdings for the quarter ended 2026-03-31, in a 13F-HR filed 2026-05-15. Its ten largest share positions make up 63.54% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001172661-26-002258

Period
2026-03-31
Reported value
$572M
Holdings
28
Top 10 weight
63.54%
New
8
Sold out
10

Largest buys vs the previous quarter

SecurityShares changeApprox. value
ASNDnew+86,650$19.8M
RAREnew+884,121$18.5M
BSXnew+293,152$18.4M
PTGXadded+122,022$12.9M
ICLRadded+111,410$12.3M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
NBIXexited-162,800-$23.1M
EXASexited-147,750-$15M
NTRAreduced-61,387-$12.3M
LEGNexited-408,652-$8.88M
ATAIBECKLEY INCexited-1,678,400-$6.86M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q1 2026

Share positions as resolved from 13F-HR 0001172661-26-002258, largest first. % of portfolio is the value over $476,295,751, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
ARGXARGENX SEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 74,990 shares; 2024Q4: 74,990 shares; 2025Q1: 74,990 shares; 2025Q2: 77,430 shares; 2025Q3: 77,430 shares; 2025Q4: 62,730 shares; 2026Q1: 76,336 shares 76,336$55.7M11.7%+13,606Timeline
ICLRICON PUB LTD COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 130,790 shares; 2024Q4: 209,190 shares; 2025Q1: 209,190 shares; 2025Q2: 202,790 shares; 2025Q3: 182,590 shares; 2025Q4: 247,090 shares; 2026Q1: 358,500 shares 358,500$39.7M8.33%+111,410Timeline
INSMINSMED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 513,700 shares; 2024Q4: 513,700 shares; 2025Q1: 443,300 shares; 2025Q2: 428,600 shares; 2025Q3: 271,600 shares; 2025Q4: 210,900 shares; 2026Q1: 224,271 shares 224,271$36.7M7.7%+13,371Timeline
GHGUARDANT HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 212,000 shares; 2025Q3: 284,100 shares; 2025Q4: 284,100 shares; 2026Q1: 310,281 shares 310,281$28.7M6.02%+26,181Timeline
BMRNBIOMARIN PHARMACEUTICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 419,212 shares; 2024Q4: 419,212 shares; 2025Q1: 382,612 shares; 2025Q2: 366,812 shares; 2025Q3: 366,812 shares; 2025Q4: 366,812 shares; 2026Q1: 505,809 shares 505,809$28.6M6%+138,997Timeline
NTRANATERA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 431,314 shares; 2024Q4: 339,764 shares; 2025Q1: 279,764 shares; 2025Q2: 235,964 shares; 2025Q3: 203,664 shares; 2025Q4: 183,264 shares; 2026Q1: 121,877 shares 121,877$24.4M5.12%-61,387Timeline
SRRKSCHOLAR ROCK HLDG CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 269,400 shares; 2025Q3: 363,300 shares; 2025Q4: 363,300 shares; 2026Q1: 494,019 shares 494,019$24.3M5.1%+130,719Timeline
ILMNILLUMINA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 387,354 shares; 2024Q4: 343,361 shares; 2025Q1: 343,361 shares; 2025Q2: 343,361 shares; 2025Q3: 322,261 shares; 2025Q4: 231,161 shares; 2026Q1: 187,413 shares 187,413$23.1M4.85%-43,748Timeline
TERNTERNS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 275,090 shares; 2026Q1: 412,497 shares 412,497$21.7M4.57%+137,407Timeline
BBIOBRIDGEBIO PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 259,300 shares; 2025Q3: 259,300 shares; 2025Q4: 259,300 shares; 2026Q1: 267,031 shares 267,031$19.8M4.16%+7,731Timeline
ASNDASCENDIS PHARMA A/SQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 56,500 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 86,650 shares 86,650$19.8M4.16%newTimeline
PTGXPROTAGONIST THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 57,300 shares; 2026Q1: 179,322 shares 179,322$18.9M3.97%+122,022Timeline
RAREULTRAGENYX PHARMACEUTICAL INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 561,700 shares; 2024Q4: 627,600 shares; 2025Q1: 627,600 shares; 2025Q2: 627,600 shares; 2025Q3: 697,000 shares; 2025Q4: not reported; 2026Q1: 884,121 shares 884,121$18.5M3.89%newTimeline
BSXBOSTON SCIENTIFIC CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 293,152 shares 293,152$18.4M3.86%newTimeline
FTREFORTREA HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 988,772 shares; 2025Q4: 1,218,560 shares; 2026Q1: 1,307,560 shares 1,307,560$12.3M2.59%+89,000Timeline
KYMRKYMERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 136,300 shares; 2026Q1: 145,816 shares 145,816$12.1M2.55%+9,516Timeline
PRCTPROCEPT BIOROBOTICS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 233,089 shares; 2024Q4: 233,089 shares; 2025Q1: 299,089 shares; 2025Q2: 299,089 shares; 2025Q3: 308,434 shares; 2025Q4: 308,434 shares; 2026Q1: 483,815 shares 483,815$12.1M2.54%+175,381Timeline
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 115,900 shares; 2026Q1: 119,464 shares 119,464$11.6M2.44%+3,564Timeline
TEMTEMPUS AI INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 256,269 shares 256,269$11.6M2.43%newTimeline
CMPSCOMPASS PATHWAYS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 935,450 shares; 2025Q4: 1,519,388 shares; 2026Q1: 2,060,427 shares 2,060,427$11.4M2.39%+541,039Timeline
CNTACENTESSA PHARMACEUTICALS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 103,100 shares; 2025Q4: 103,100 shares; 2026Q1: 214,291 shares 214,291$8.51M1.79%+111,191Timeline
ALKSALKERMES PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 81,800 shares; 2025Q4: 81,800 shares; 2026Q1: 238,673 shares 238,673$8.44M1.77%+156,873Timeline
ATAIATAIBECKLEY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,709,359 shares 1,709,359$6.05M1.27%newTimeline
ISRGINTUITIVE SURGICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 7,390 shares; 2024Q4: 4,390 shares; 2025Q1: 4,390 shares; 2025Q2: 4,390 shares; 2025Q3: 4,390 shares; 2025Q4: 4,390 shares; 2026Q1: 4,390 shares 4,390$2.02M0.42%0Timeline
IMCRIMMUNOCORE HLDGS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 46,300 shares; 2024Q4: 46,300 shares; 2025Q1: 46,300 shares; 2025Q2: 46,300 shares; 2025Q3: 46,300 shares; 2025Q4: 46,300 shares; 2026Q1: 46,300 shares 46,300$1.4M0.29%0Timeline
FRNMPERCEPTIVE CAP SOLUTIONS CORQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 37,686 shares 37,686$413K0.09%newTimeline

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
XBISPDR SERIES TRUST S&P BIOTECHput730,000$93.2Mnew
PRCTPROCEPT BIOROBOTICS CORP Stockcall90,000$2.25Mnew

Sold out in Q1 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
NBIXNEUROCRINE BIOSCIENCES INC162,800$23.1Mshares
EXASEXACT SCIENCES CORP147,750$15Mshares
LEGNLEGEND BIOTECH CORP408,652$8.88Mshares
ATAIBECKLEY INCATAIBECKLEY INC1,678,400$6.86Mshares
SLNOSOLENO THERAPEUTICS INC135,100$6.26Mshares
QUREUNIQURE NV205,247$4.91Mshares
PRAXPRAXIS PRECISION MEDICINES I14,951$4.41Mshares
MLTXMOONLAKE IMMUNOTHERAPEUTICS187,600$2.47Mshares
IRONDISC MEDICINE INC27,100$2.15Mshares
VIRVIR BIOTECHNOLOGY INC240,500$1.45Mshares

How Q1 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001172661-26-002258 base2026-05-15acceptance time not in the bulk data set